Clinitech Laboratory IPO is a fixed price issue of Rs 5.78 crores. The issue is entirely a fresh issue of 6.02 lakh shares.
Clinitech Laboratory IPO opens for subscription on July 25, 2024 and closes on July 29, 2024. The allotment for the Clinitech Laboratory IPO is expected to be finalized on Tuesday, July 30, 2024. Clinitech Laboratory IPO will list on BSE SME with tentative listing date fixed as Thursday, August 1, 2024.
Clinitech Laboratory IPO price is ₹96 per share. The minimum lot size for an application is 1200 Shares. The minimum amount of investment required by retail investors is ₹115,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹230,400.
Inventure Merchant Banker Services Pvt Ltd is the book running lead manager of the Clinitech Laboratory IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Clinitech Laboratory IPO is Svcm Securities.
Refer to Clinitech Laboratory IPO RHP for detailed information.
Clinitech Laboratory IPO Details
| IPO Date | July 25, 2024 to July 29, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹96 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 602,400 shares (aggregating up to ₹5.78 Cr) |
| Fresh Issue | 602,400 shares (aggregating up to ₹5.78 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 1,680,000 |
| Share holding post issue | 2,282,400 |
| Market Maker portion | 31,200 shares Svcm Securities |
Clinitech Laboratory IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Retail Shares Offered | 50% of the Net Issue |
| Other Shares Offered | 50% of the Net issue |
Clinitech Laboratory IPO Timeline (Tentative Schedule)
Clinitech Laboratory IPO opens on July 25, 2024, and closes on July 29, 2024.
| IPO Open Date | Thursday, July 25, 2024 |
| IPO Close Date | Monday, July 29, 2024 |
| Basis of Allotment | Tuesday, July 30, 2024 |
| Initiation of Refunds | Wednesday, July 31, 2024 |
| Credit of Shares to Demat | Wednesday, July 31, 2024 |
| Listing Date | Thursday, August 1, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 29, 2024 |
Clinitech Laboratory IPO Lot Size
Investors can bid for a minimum of 1200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹115,200 |
| Retail (Max) | 1 | 1200 | ₹115,200 |
| HNI (Min) | 2 | 2,400 | ₹230,400 |
| Lot Size Calculator | |||
Clinitech Laboratory IPO Promoter Holding
Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak are the promoters of the company.
| Share Holding Pre Issue | 83.63% |
| Share Holding Post Issue | 61.56% |
About Clinitech Laboratory Limited
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.
The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.
Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.
The company’s medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.
As of May 31, 2024, the company employed 85 people in various departments.
Clinitech Laboratory Limited Financial Information (Restated)
Clinitech Laboratory Limited’s revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 560.79 | 603.33 | 368.74 | 273.32 |
| Revenue | 643.92 | 636.34 | 645.70 | 459.63 |
| Profit After Tax | 37.12 | 61.31 | 51.26 | 40.24 |
| Net Worth | 354.80 | 238.08 | 184.81 | 139.03 |
| Reserves and Surplus | 186.80 | 88.08 | 34.81 | 72.37 |
| Total Borrowing | 86.31 | 102.91 | 88.61 | 53.67 |
| Amount in ₹ Lakhs | ||||
Key Performance Indicator
The market capitalization of Clinitech Laboratory IPO is Rs 21.91 Cr.
KPI as of March 31, 2024.
| KPI | Values |
|---|---|
| Debt/Equity | 0.24 |
| RoNW | 10.46% |
| P/BV | 4.55 |
| PAT Margin (%) | 5.76 |
Check Clinitech Laboratory IPO Peer Comparison here.
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 2.21 | 1.63 |
| P/E (x) | 43.45 | 59.03 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2024 that is available in RHP.
Objects of the Issue (Clinitech Laboratory IPO Objectives)
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Expansion of Diagnostic Centres; and
- General Corporate Purposes.
Clinitech Laboratory IPO Review (Avoid)
[Dilip Davda] The company is operating in a highly competitive and fragmented segment. It marked almost static top lines for the reported periods and boosted bottom line for FY24. Based on FY24 super earnings, the issue is exorbitantly priced. There is no harm in skipping this risky bet. Read detail review…
Clinitech Laboratory IPO Prospectus
Clinitech Laboratory Limited Contact Details
Clinitech Laboratory Limited
AL-1/545, Sector 16, Airoli
Opposite Radhikabai Meghe Vidyalaya
Navi Mumbai, Thane – 400708,
Phone: +91 22 27792281
Email: ipo@clinitechlab.com
Website: https://clinitechlab.com/
Clinitech Laboratory IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html